Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1475 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Creabilis names new CEO

Most recently, Forster was the CEO of Solace Pharmaceuticals. Before joining Solace Pharma, Forster was the head of EU Development and of Development Operations in the EU &

HUYA, Quintiles to co-develop HBI-8000

HBI-8000 has now entered into a Phase I clinical trial in the US under an IND application with the FDA. HBI-8000 trial is designed to assess safety, tolerability